Skip to content

Clinical trials

Completed Phase 4 Essential Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Essential Hypertension Phase: Phase 4 Status: Completed Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20043
20053
20063
20073
20085
20093
20103
20111
20122
20132
20144
20154
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis4
GlaxoSmithKline2
Organon and Co2
Aarhus University Hospital1
Assistance Publique - Hôpitaux de Paris1
AstraZeneca1
Beata Krasinska1
Boryung Pharmaceutical Co., Ltd1
Centre for Chronic Disease Control, India1
Chong Kun Dang Pharmaceutical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Essential Hypertension40
Hypertension15
Diabetes Mellitus, Type 24
Cardiovascular Diseases3
Stroke2
Diabetes Mellitus1
Diabetic Nephropathies1
Heart Failure1
Hypertrophy, Left Ventricular1
Hyperuricemia1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.